March 20, 2026 a 09:03 amUm eine detaillierte technische Analyse von Charles River Laboratories International, Inc. (CRL) zu geben, werde ich die bereitgestellten Daten verwenden, um die mittleren gleitenden Durchschnitte (EMA20 und EMA50) zu berechnen und die Unterstützungs- und Widerstandszonen zu identifizieren.
CRL: Trend and Support & Resistance Analysis - Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is positioned in the pharmaceutical and biotechnology sectors, offering a range of non-clinical services crucial for drug discovery and safety operations globally. With its diversified operations, from research models to manufacturing solutions, CRL plays a vital role in the healthcare supply chain. Its recent stock performance reflects broader industry trends and the internal financial dynamics of the company.
Trend Analysis
The recent trend analysis based on daily closing prices indicates the following:
| Date | Closing Price (USD) | Trend |
|---|---|---|
| 2026-03-19 | 153.05 | ▼ |
| 2026-03-18 | 157.11 | ▲ |
| 2026-03-17 | 153.71 | ▼ |
| 2026-03-16 | 151.97 | ▼ |
| 2026-03-13 | 155.46 | ▲ |
| 2026-03-12 | 152.66 | ▼ |
| 2026-03-11 | 168.91 | ▲ |
The calculated EMAs show that the EMA20 is currently below the EMA50, indicating a continuing ▼ downward trend. This suggests bearish sentiment among traders, potentially due to underlying market conditions or company-specific news impacting the stock negatively. Analyze caution as the market may still be volatile.
Support- and Resistance
Following an examination of recent price movements and historical data, the following support and resistance zones have been identified:
| Zone | From (USD) | To (USD) | |
|---|---|---|---|
| Support 1 | 150.00 | 153.00 | ▲ |
| Support 2 | 145.00 | 148.00 | ▲ |
| Resistance 1 | 168.00 | 171.00 | ▼ |
| Resistance 2 | 175.00 | 178.00 | ▼ |
The current price is near the lower support zone, which may provide a potential rebound point, but a confirmed breakdown below the support might lead to further downside risk.
Conclusion
In summary, the current market analysis of CRL indicates a bearish trend, as demonstrated by the EMA calculations and recent closing prices. The proximity to the support zone suggests potential volatility, and traders should remain cautious. Given the company's strong positioning in the drug discovery and testing sectors, external market factors and sector trends could significantly influence its stock performance. Continuous monitoring of market updates and company disclosures is advisable to navigate potential risks and opportunities effectively.
json These calculations and interpretations are based on the provided historical data. Amendments or updates in market conditions may change the overall analysis.